Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/1999
11/10/1999CN1046204C Oral liquor for building body and strengthening 'Yang'
11/10/1999CN1046192C Method for production of dedorized fish oil microcapsule
11/09/1999US5981508 Facilitation of repair of neural injury with CM101/GBS toxin
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981473 Composition and method for treating acne
11/09/1999US5981275 Plasmid comprising heterologous genes linked to cytomegalo virus promoters and stably produces heterologous gene product; for delivery to cells
11/09/1999US5981254 Salting out plasma proteins, diafiltering and diluting supernatant containing prothrombin, acidic precipitation, solubilizing, converting to thrombin, deactivating lipid containing viruses, chromatographic purification; safe glues
11/09/1999US5981211 Continuous production of cell product from animal tissues or geneticaly engineered cells by trapping cells in insoluble, cell compatible matrix; supplying nutrient medium; withdrawing waste; withdrawing prodduct
11/09/1999US5981165 Exogenous activation and expression of tyrosine hydroxylase in neural cells; culturing mammalian cells of central nervous system; treatment for parkinson's disease and other nervous system disorders
11/09/1999US5980954 Modifying the extracted blood aliquot from patient by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation, forming an autoimmune vaccine to treat rheumatoid arthritis
11/09/1999US5980953 Anti-inflammatory factor, method of isolation, and use
11/09/1999US5980901 Viral defective interfering particles and uses thereof
11/09/1999US5980898 Adjuvant for transcutaneous immunization
11/09/1999US5980887 Methods for enhancing angiogenesis with endothelial progenitor cells
11/09/1999US5980885 Growth factor-induced proliferation of neural precursor cells in vivo
11/04/1999WO1999056126A2 Immuno-adsorption matrix, a method for the production thereof, and the utilization thereof
11/04/1999WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences
11/04/1999WO1999055843A2 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/04/1999WO1999055838A1 Compositions and methods for the characterization and transplantation of mammalian retinal stem cells
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055379A1 A process of delivering a polynucleotide to a cell via the vascular system
11/04/1999WO1999055378A1 Method of treating endotoxemia
11/04/1999WO1999055360A1 Implantable system with drug-eluting cells for on-demand local drug delivery
11/04/1999WO1999055357A1 Method for the treatment of fertility disorders
11/04/1999WO1999055349A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999WO1999055348A2 Stabilised virus preparation
11/04/1999WO1999055347A2 Treatment of papilloma virus infection using a mycobacterium
11/04/1999WO1999055346A1 Method for preparing a diafiltered stabilized blood product
11/04/1999WO1999055345A1 Combination viral-based and gene-based therapy of tumors
11/04/1999WO1999046381A3 Human fgf gene and gene expression products
11/04/1999WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor
11/04/1999WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/04/1999WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999DE19818098A1 Implant with improved tissue integration
11/04/1999CA2330387A1 Treatment of papilloma virus infection using a mycobacterium
11/04/1999CA2330033A1 Method of treating endotoxemia
11/04/1999CA2329301A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999CA2327506A1 Combination viral-based and gene-based therapy of tumors
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326378A1 Efficient ex vivo expansion of cd4+ and cd8+ t-cells from hiv infected subjects
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953633A1 Cell culturing method and medium for producing proliferated, normal, differentiated human liver cells
11/03/1999EP0953352A1 A therapeutic agent for ischemic diseases
11/03/1999EP0953351A2 Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
11/03/1999EP0953040A1 Skin regeneration using mesenchymal stem cells
11/03/1999EP0952986A1 Antimicrobially active polypeptides
11/03/1999EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999EP0952824A1 Enteric coating, comprising alginic acid, for an oral preparation
11/03/1999EP0952773A1 Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
11/03/1999EP0952772A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
11/03/1999EP0778944B1 Cell separation apparatus and method
11/03/1999CN1234117A Use of anti-embryonic hemoglobin antibodies to identify fetal cells
11/03/1999CN1234075A Retroviral vector
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1233961A Apoptosis inducers
11/03/1999CN1233487A Medicine for treating hepatitis B
11/03/1999CN1233483A Traditional Chinese medicine for treating cirrhosis and liver cancer
11/03/1999CN1233474A Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
11/03/1999CN1233473A Medicinal prepn. beverage contg. scorpion juice
11/03/1999CN1233470A Electrolysis of water resulting in reduction of fat content in human liver
11/03/1999CN1046092C Health-care medicine for treating senile's weak or the like
11/03/1999CN1046091C Oolong medicinal products, pellet or tablet thereof
11/02/1999US5977433 Maintenance of male-sterile plants
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977176 Compositions for the treatment of warts and herpes
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976539 Compositions and methods for use of IL-12 as an adjuvant
11/02/1999US5976526 Injectable bladder muscle cells-polymer suspension for treatment of vesicoureteral reflux and incontinence
11/02/1999US5976524 That produces urine and develops a ureter that facilitates externalization of the urine.
11/02/1999CA1340809C Process for producing a novel antifungal product from pediococcus sp.
10/1999
10/30/1999CA2270754A1 Selection process for bacterial strain
10/28/1999WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054354A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
10/28/1999WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999WO1999053949A2 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999WO1999053942A1 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
10/28/1999WO1999053932A1 Streptococcus preparation
10/28/1999WO1999053775A1 Propionibacterium p-63 for use in direct fed microbials for animal feeds
10/28/1999WO1999053762A1 A method for efficient and highly selective control of microorganisms
10/28/1999WO1999040180A3 Expanded and genetically modified populations of human hematopoietic stem cells
10/28/1999WO1999035255A3 Compositions and methods for regulated secretion from neuroendocrine cell lines
10/28/1999WO1999035245A3 Methods for preparing and using immortalized human neuroendocrine cells
10/28/1999WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19818790A1 Preparation of an immuno-adsorption matrix, useful for diagnostic and therapeutic purposes
10/28/1999CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999CA2328967A1 A method for efficient and highly selective control of microorganisms
10/28/1999CA2326406A1 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999CA2325805A1 Streptococcus preparation
10/28/1999CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999EP0951909A1 Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 1259